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In a recent issue of Critical Care, Cheng and colleagues
conducted a rabbit model study that demonstrated that
intra-abdominal hypertension (IAH) may damage both
gut anatomy and function. With only 6 hours of IAH at
25 mmHg, these authors observed an 80% reduction in
mucosal blood flow, an exponential increase in mucosal
permeability, and erosion and necrosis of the jejunal villi.
Such dramatic findings should remind all caring for the
critically ill that IAH may severely damage the normal gut
barrier functions and thus may be reasonably expected
to facilitate bacterial and mediator translocation. The
potential contribution of IAH as a confounding factor in
the efficacy of selective decontamination of the digestive
tract should be considered.onstrated to improve outcome related to a reduction of theUsing a rabbit model, Cheng and colleagues [1] demon-
strated that intra-abdominal hypertension (IAH) dramatically
damages the anatomy and function of the gastrointestinal
tract (gut). The authors utilized a rigorous design to
examine gut form and function subjected to IAH through
multiple methodologies, namely by studying perfusion,
intestinal permeability, and the structural integrity by both
light and electron microscopy [1].
The gut represents the largest body surface in contact
with the external environment and constitutes a reservoir
of more than 100 trillion bacteria [2]. However, unlike with
many other organs and/or body systems that are readily
monitored clinically, radiologically, or through invasive
techniques, clinical examination of the abdomen represents
the standard for gut function monitoring. The gut therefore
may be considered a clinically silent organ system that may* Correspondence: andrew.kirkpatrick@albertahealthservices.ca
1Department of Surgery, University of Calgary, Foothills Medical Centre,
Calgary, Alberta T2N 2T9, Canada
2Department of Community Health Sciences, University of Calgary, Foothills
Medical Centre, Calgary, Alberta T2N 2T9, Canada
Full list of author information is available at the end of the article
© Kirkpatrick et al.; licensee BioMed Cen
for 12 months following its publication. After
Attribution License (http://creativecommons.o
reproduction in any medium, provided the or
2014be a ‘ticking time-bomb’ in many admitted to the critical
care unit. Multiple organ dysfunction syndrome (MODS) is
well feared as a leading cause of morbidity, mortality, and
resource use in critical care units [3,4]. For more than half
a century it has been hypothesized that the gut is the motor
of a catastrophic sequence of events that ultimately results
in MODS [2,5]. The theory is that translocation of aerobic
Gram-negative bacilli and/or absorption of their resultant
endotoxin contributes to a systemic inflammatory state
resulting in widespread organ dysfunction, tissue damage,
and subsequent MODS [5].
Postulation of the gut in this role has led to the develop-
ment of selective digestive decontamination (SDD) proto-
cols wherein antimicrobials are utilized to reduce gut
bacterial load. These protocols utilize both broad-spectrum
parenteral and enteral antimicrobials, and have been dem-
severity and/or incidence of MODS by the prevention of
infection, gut overgrowth, aerobic Gram-negative bacilli
translocation, and endotoxin absorption [5,6]. This seem-
ingly simple solution to such a challenging problem has
tantalized generations of physicians. Gut decontamination
is one of the most persistently researched areas in critical
care with no less than 65 randomized trials involving over
15,000 patients that have generated 11 meta-analyses by
the end of 2011 [7]. Despite such efforts, however, use of
SDD remains highly controversial, with widely divergent
opinions ranging from scepticism [7,8] to belief that it
represents standard of care [7,9]. Some of these divergent
views arise related to concerns about development of anti-
microbial resistance as well as from the analysis of the data
involving subgroup analysis, surrogate outcomes, and post
hoc analyses [5]. Continuing investigations are thus under-
way in an effort to better understand how SDD may work,
who it may best benefit, and how it may influence
emergence of resistant organisms.tral Ltd. The licensee has exclusive rights to distribute this article, in any medium,
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number of important questions surrounding the genesis of
MODS and the use of SDD. It is commonly assumed that
shock is the precipitating factor that results in gut hypo-
perfusion and initiation of MODS, and this seems likely to
be the case in many patients who present with early shock.
However, it poorly explains the later development of
MODS in patients where shock resuscitation has been
prompt. There is an increasing body of evidence that
development of IAH may be a major contributor in this
case. The theory and rationale underlying the potential
benefit of SDD on the other hand is related to reducing
organism burden and subsequent translocation by a sick-
ened gut. As an upstream event, enhanced measures to
maintain gut health, such as preventing IAH, might be of
greater value in preventing MODS. At the least, future
SDD investigations need to consider and control for IAH
as a potential covariate.
The results of Cheng and associates are important in
emphasizing the dangers of IAH. The World Society of the
Abdominal Compartment Syndrome recently published
updated Consensus Guidelines [10], which revalidated the
definition and gradation of IAH as originally proposed to
understand and study concerns regarding pathologically
raised intra-abdominal pressure in the critically ill [11,12].
IAH is classified as grade I, 12 to 15 mmHg; grade II, 15 to
20 mmHg; grade III, 20 to 25 mmHg; and grade IV,
>25 mmHg [10]. While it is uncertain and even unlikely
that pressure thresholds derived from animals completely
correlate with human values, it is pertinent that what might
erroneously be considered ‘mild’ grade I IAH (15 mmHg)
had profound effects on mucosal blood flow, which was
reduced by 50% after only 4 hours. When IAH was even
more severe (in the range commensurate with abdominal
compartment syndrome (defined as intra-abdominal pres-
sure >20 associated with new organ failure [10,13])), there
was profound injury to the gut. Nearly 20 years ago Diebel
and colleagues [14] demonstrated that similar degrees of
IAH in a rodent model were associated with bacterial trans-
location to the mesenteric lymph nodes. To date, however,
no group has correlated the dose-effect of the pathophysi-
ology and histology of IAH-induced gut injury so elegantly
as Cheng and colleagues. Generalizing results of animal
model studies to bedside management of patients must be
done with caution, as it is recognized that such studies will
never be truly replicated clinically. In any case, this import-
ant study conducted by Cheng and colleagues should be a
prompt for greater recognition of the adverse effects of
IAH in the critically ill and stresses the importance of
evaluating IAH as a covariate in future studies investigating
the pathophysiology or management of MODS.
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